Correction: Toll-like reReceptor 8 agonists improve NK-cell function primarily targeting CD56(bright)CD16(−) subset

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932264/
https://www.ncbi.nlm.nih.gov/pubmed/35301237
http://dx.doi.org/10.1136/jitc-2021-003385corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932264/
https://www.ncbi.nlm.nih.gov/pubmed/35301237
http://dx.doi.org/10.1136/jitc-2021-003385corr1

Ejemplares similares